Topical therapy of combined inflammatory diseases of the pharynx and oral cavity
https://doi.org/10.21518/2079-701X-2019-8-18-27
Abstract
In the development of inflammatory diseases of the pharynx, etiological factors may include viral agents, bacterial infection, mainly streptococcal nature, fungal infection, diseases of the gastrointestinal tract (GERD, gastritis). Inflammatory changes in the oral mucosa and pharynx can be manifested by the main symptoms such as a feeling of dryness in the mouth and throat, difficulty or pain when swallowing. Xerostomy is a condition that develops when saliva secretion decreases or stops and is characterized by dryness in the oral cavity. With long-term course is accompanied by psycho-emotional disorders and contributes to the development of dental diseases (stomatitis, gingivitis). Septolete total including substances such as cetylpyridinium chloride and benzidamine, has antimicrobial and anti-inflammatory and can be used as an effective etiotropic and pathogenetic therapy of inflammatory diseases of the pharynx. It is also possible to use after otorhinolaryngological interventions(tonsilectomy).
About the Authors
S. V. Morozova
Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of
the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Dr. of Sci. (Med.), Professor of Chair for Ear, Nose & Throat Diseases, Federal State Autonomous Educational Institution of Higher Education «Sechenov First Moscow State Medical University» of the Ministry of Heath of the Russian Federation (Sechenov University)
Russian Federation
Dr. of Sci. (Med.), Professor of Chair for Ear, Nose & Throat Diseases, Federal State Autonomous Educational Institution of Higher Education «Sechenov First Moscow State Medical University» of the Ministry of Heath of the Russian Federation (Sechenov University)
E. M. Pavlyshina
Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of
the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
an otorhinolaryngologist, Ear, Nose & Throat Clinic, Federal State Autonomous Educational Institution of Higher Education «Sechenov First Moscow State Medical University» of the Ministry of Heath of the Russian Federation (Sechenov University)
Russian Federation
an otorhinolaryngologist, Ear, Nose & Throat Clinic, Federal State Autonomous Educational Institution of Higher Education «Sechenov First Moscow State Medical University» of the Ministry of Heath of the Russian Federation (Sechenov University)
References
1. Acute tonsillopharyngitis. Clinical guidelines, 2016, KR 306, 6-18.] (In Russ.)
2. Karneeva O.V., Dajhes N.A., Polyakov D.P. Protocols for the diagnosis and treatment of acute tonsillopharyngitis. RMJ. Otorinolaringologiya. 2015;(6):307-311.] (In Russ.)
3. Aref’eva N.A. Tonsillary pathology. Status update on the problem. Vestnik Otorinolaringologii. 2012;6:10–13.] (In Russ.)
4. Lukovskij L.A. New data to justify uniform clinical classification of tonsillitis. Serdechno-Sosudistaya Patologiya. 1966:259– 266.] (In Russ.)
5. Guide to otorhinolaryngology.Under the editorship of I.B. Soldatova. M.: Medicina, 1994. 608 p.] (In Russ.)
6. Antoniv V.D., Perekrest A.I., Korotkova T.V. Some aspects of the tonsillary problem at present stage. Vestnik Otorinolaringologii. 1995;6:43–46.] (In Russ.)
7. Gurov A.V., Polivoda A.M., Polyakova T.S. Modern view on the issue of treatment of tonsillopharyngitis. RMJ. 2007;15(2):146.] (In Russ.)
8. Dergachev B.S. Differentiated approach to the treatment of chronic tonsillitis: Materials of the XVI Congress of Otorhinolaryngologists of the Russian Federation. Sochi, March 21–24, 2001 359–364.] (In Russ.)
9. Pal’chun V.T., Luchihin L.A., Kryukov A.I., Inflammatory diseases of the pharynx. A guide for practitioners. M.: GEOTARMedia,2007. 288 p.] (In Russ.)
10. Pluzhnikov M.S., Lavrenova G.V., Nikitin K.A. Angina and chronic tonsillitis. SPb.,2002. 145 p.] (In Russ.)
11. Polyakova E.P., Polyakova T.S. Chronic tonsillitis: diagnosis, treatment, prevention. RMJ. 2004;12(2):65–69.] (In Russ.)
12. Andreev V.N. Damage of the internal organs in chronic tonsillitis in the decompensation phase. Zdravookhranenie Kishineva.1984;6:26–28.] (In Russ.)
13. Babich N.F., Pavlyukova E.N. M., 1990. New in the diagnosis of the effect of chronic tonsillitis on the development of myocardial dystrophy: Materials of scientific-practical. conf. ORL and Extended Plenum RNOLO P. 141–144.] (In Russ.)
14. Dergachev V.S., Rylina M.A., et al. The immunoendocrine relationship status in patients with chronic tonsillitis. Novosti Otorinolaringologii i Logopatologii 1997;4(12):50–51.] (In Russ.)
15. Palchun V.T. Classification and treatment tactics for chronic tonsillitis. Vestnik Otorinolaringologii. 2013;3:8–11.] (In Russ.)
16. Preobrazhenskij B.S. Chronic tonsillitis and its association with other diseases. M., 1954. 57 p.] (In Russ.)
17. Oko A., Niemir Z. et al. The effect of tonsillectomy on the level of circulating immune complexes and urine changes in patients with glomerulonephritis. Polskie Archiwum Medicyni Wewntznej. 1997;97(6):518.
18. Feklisova L.V., Kazakova S.P., Galkina L.A. Mucous membranes microbiocenosis of the oropharynx in children with angina. Detskie Infektsii. 2006;2:27-31.] (In Russ.)
19. Bykova V.P. Modern aspect of tonsillary disease. Arkhiv Patologii. 1996;3:22–30.] (In Russ.)
20. Pluzhnikov M.S., Lavrenova G.V., Levin M.YA., Nazarov P.G., Nikitin K.A. Chronic tonsillitis: clinical presentation and immunological aspects. SPb: Dialogue2005. 221 p.] (In Russ.)
21. Ponomarev L.E., SHubich M.G. Topical issues of tonsillar immunology. Novosti Otorinolaringologii i Logopathologii. 1998;2:105–110.] (In Russ.)
22. Svistushkin V.M., Nikiforova G.N., Dedova M.G., Shevchik E.A. Optimization of the postoperative period in patients with chronic tonsillitis. RMJ. 2015;6:326-331.] (In Russ.)
23. Kirasirova E.A., Gorban D.G., Lafutkina N.V., et al. Approaches to the management of patients with complicated tonsillogenic infection. Vestnik Otorinolaringologii 2010;2:58–59.] (In Russ.)
24. Ahmed A.O., Aliyu I., Kolo E.S. Indications for tonsillectomy and adenoidectomy: Our experience. Niger J. Clin. Pract. 2014;17(Issue 1):90–94.
25. Bell P.R., Hall S.J., Ferguson G. Increasingly hard to swallow - 18 years of changing tonsillectomy practice in Northern Ireland. Ulster Med. J. 2013;82(2):121–125.
26. Costales-Marcos М., Lopes-Alvares F., Nunez-Batalla F. et al. Peritonsillar infection: prospective study of 100 consecutive cases. Acta Otorrinolaringol Eps. 2012:468–475.
27. Svistushkin V.M., Sin’kov E.V. Use of radio-wave surgery in otorhinolaryngology. RMJ. 2015;6:320-321.] (In Russ.)
28. Ron’ G.I. Xerostomia, Yekaterinburg: Premium Press LLC, 2008. 136 p.] (In Russ.)
29. Nederfors T. Xerostomia and hyposalivation. Adv Dent Res. 2000;14:48–56.
30. Thomson W.M., Chalmers J.M., Spencer A.J., Williams S.M. The Xerostomia Inventory: a multi-item approach to measuring dry mouth. Community Dent Health. 1999 Mar;16(1):12-7.
31. Denisov A.B., Mechanisms of pathological and adaptive processes in salivary glands diseases: an experimental study: Dr. of Sci. (Med.) Dissertation. M.1995. 296 p.] (In Russ.)
32. Pozharitskaya M.M. The role of saliva in the physiology and development of the pathological process in the hard and soft tissues of the oral cavity. Xerostomia (Methodology Guide). M.: GOUVUNMTS MZ RF 2001. 48 p.] (In Russ.)
33. Busato I.M., Ignácio S.A., Brancher J.A., Grégio A.M., Machado M.A., Azevedo-Alanis L.R. Impact of xerostomia on the quality of life of adolescents with type 1 diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Sep;108(3):376-82.
34. Osokin M.V. The salivary glands state in patients with chronic renal failure in the terminal stage: Dr. of Sci. (Med.) Dissertation. M.2007. 101 p.] (In Russ.)
35. Vasil’ev V.I., Lihvanceva V.G., Safonova T.N. Sjogren syndrome: a guide for practitioners. M., 2013. 600 p.] (In Russ.)
36. Lobejko V.V., Iordanishvili A.K. Radiation sialoadenopathies in elderly and old people and their treatment. Vestnik Rossiyskoy Voenno-Medicinskoy Akademii 2014;1(45):75-79.] (In Russ.)
37. Billings R.J., Proskin H.M., Moss M.E. Xerostomia and associated factors in a community-dwelling adult population. Community Dent Oral Epidemiol. 1996;24:312–316.
38. Madinier I., Jehl-Pietri C., Monteil R.A. Les hypo sialiesd’originemedicamenteuse. Ann Med Interne 1997;148:398-405.
39. Baranovskij A.L. Consilium Provisorum. Dry Mouth. Consilium Provisorum. 2002;2(8):22-24.] (In Russ.)
40. Grinin V.M., Korsakova T.V. Oral Balance artificial saliva and its role in xerostomia syndrome. DentalMarket.2003;2:13-15.] (In Russ.)
41. Hetagurov V.V. et al. Use of saliva replacement gel in the orthopedic treatment of patients with xerostomia. Panorama Ortopedicheskoy Stomatologii 2001;4:25-29] (In Russ.)
42. Hetagurov V.V. et al. Use of saliva replacement gel in the orthopedic treatment of patients with xerostomia. Panorama Ortopedicheskoy Stomatologii 2001;4:25-29] (In Russ.)
43. Podvyaznikov S.O. A brief look at the problem of xerostomia. Opukholi Golovy i Shei. 2015;5(1):42-44.] (In Russ.)
44. Komarova K.V., Ratkina N.N. Dental status of patients with xerostomia. Sovremennye Problemy Nauki i Obrazovanie..2013;6:570.] (In Russ.)
45. Kryukov A.I., Kunel’skaya N.L., Carapkin G.Yu., Izotova G.N., Tovmasyan A.S., Kiseleva O.A. Symptomatic therapy for temporary xerostomia in patients after surgical interventions on the nasal cavity and pharynx structures. Meditsinsky Sovet.2014;1:40-44.] (In Russ.)
46. Kryukov A.I. Etiotropic and pathogenetic therapy of oropharyngeal pain. Meditsinsky Sovet. 2015;3.] (In Russ.)
47. Koir P. A comparison of therapeutic equivalence between test andreference formulations of the fixed combination of 3 milligrams benzydamine hydrochloride and 1 milligram cetylpyridinium chloride in the treatment of sore throat associated with upper respiratorytract infections. Med Razgl. 2015;54(Suppl 3): 33–42.
48. Wething J.F. Double blind study of benzydamamine hydrochloride,a new threatment for sore throat. Clin. Ther. 1985;7(5):641-6.
49. Zabolotnyy D.I. et al. Treating of chronic pharyngitis at the stage of aggravation: clinical, immunological and microbiological aspects. Zdorovja Ukraini. The Medical Journal. 2007;19(176):1-3.
50. Košir P. Clinical experience with Septolete plus products in the treatment of sore throat. KRKA Med Farm. 2014;26(38):136-143.
51. Gurov A.V., Yushkina M.A., Guseva O.A. Local therapy of inflammatory oropharynx diseases. Trudny Patsient. 2018;3(16):41-46. (In Russ.)
Review
For citations:
Morozova SV, Pavlyshina EM. Topical therapy of combined inflammatory diseases of the pharynx and oral cavity. Meditsinskiy sovet = Medical Council. 2019;(8):18-27. (In Russ.) https://doi.org/10.21518/2079-701X-2019-8-18-27
Views:
951
Email this article 